Subscribe to our weekly International update on Health Policies
On 6 October 2025, the World Health Organization (WHO) announced the prequalification of lenacapavir, a breakthrough long-acting injectable medicine for HIV prevention. The news was rapidly spread across general and specialized media. But a key question remains unaddressed: what does WHO prequalification really add for a medicine already approv...
Historically, limited access to medicines was viewed as a problem primarily affecting healthcare systems in the Global South. However, in recent years this issue has also emerged in the Global North, thus transforming access to medicines into a global concern extending beyond low-resource settings. Moreover, access to medicines is nowadays add...
These days, it’s rare to come across a story of international consensus. However, during the 67th session of the Commission of Narcotic Drugs (CND) of the United Nations Office on Drugs and Crime (UNODC) in Vienna, member states reached an important agreement. Resolution 67/4, adopted by consensus at CND67, aims to enhance the availability o...
On December 6th, 2023, the European Medicines Agency (EMA) in collaboration with the EU Heads of Medicines Agencies (HMA) released the first-ever European List of Critical Medicines. This list includes 200 medicines whose “continued supply is considered a priority in the EU, to avoid serious harm to patients and help healthcare systems funct...
